We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc
SPPI

Delisted

SPPI was delisted on the 31st of July, 2023.

Back to rankings

75 hedge funds and large institutions have $22.7M invested in Spectrum Pharmaceuticals Inc in 2022 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 18 increasing their positions, 25 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more call options, than puts

Call options by funds: $351K | Put options by funds: $231K

13% less funds holding

Funds holding: 86 → 75 (-11)

28% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 25

30% less capital invested

Capital invested by funds: $32.3M → $22.7M (-$9.61M)

42% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 26

Holders
75
Holders Change
-11
Holders Change %
-12.79%
% of All Funds
1.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
18
Reduced
25
Closed
26
Calls
$351K
Puts
$231K
Net Calls
+$120K
Net Calls Change
-$325K

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$1.05M
2
Bank of America
Bank of America
North Carolina
+$704K
3
GCP
GSA Capital Partners
United Kingdom
+$626K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$584K
5
CCM
CAAS Capital Management
New York
+$280K

Top Sellers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$4.13M
2
Millennium Management
Millennium Management
New York
-$1.11M
3
Citadel Advisors
Citadel Advisors
Florida
-$742K
4
BlackRock
BlackRock
New York
-$648K
5
Fisher Asset Management
Fisher Asset Management
Washington
-$425K
Name Holding Trade Value Shares
Change 		Change in
Stake
RJFSA
51
Raymond James Financial Services Advisors
Florida
$6K +$215 +219 +2%
IA
52
IFP Advisors
Florida
$6K +$290 +295 New
PA
53
Parallel Advisors
California
$6K +$3.93K +4,000 +40%
JP Morgan Chase
54
JP Morgan Chase
New York
$5K -$31.6K -32,131 -73%
TRCT
55
Tower Research Capital (TRC)
New York
$5K +$1.36K +1,386 +14%
IAA
56
Independent Advisor Alliance
North Carolina
$5K +$10.6K +10,800 New
MC
57
Moors & Cabot
Massachusetts
$5K +$12.2K +12,400 New
MWM
58
Mission Wealth Management
California
$4K – – –
NFC
59
Northeast Financial Consultants
Connecticut
$4K – – –
Vontobel Holding
60
Vontobel Holding
Switzerland
$4K +$9.83K +10,000 New
Citigroup
61
Citigroup
New York
$1K -$2.06K -2,096 -50%
KFI
62
Key Financial Inc
Pennsylvania
$1K – – –
PVH
63
Psagot Value Holdings
Israel
$1K – – –
SPIA
64
Steward Partners Investment Advisory
New York
$1K – – –
UBS Group
65
UBS Group
Switzerland
$1K +$35 +36 +2%
CUAMC
66
China Universal Asset Management Company
China
$1K +$1.73K +1,763 New
FDCDDQ
67
Federation des caisses Desjardins du Quebec
Quebec, Canada
$688 – – –
BNP Paribas Financial Markets
68
BNP Paribas Financial Markets
France
$555 -$29.8K -30,361 -96%
Citadel Advisors
69
Citadel Advisors
Florida
– -$742K -755,128 Closed
Fisher Asset Management
70
Fisher Asset Management
Washington
– -$425K -545,198 Closed
AQR Capital Management
71
AQR Capital Management
Connecticut
– -$126K -161,832 Closed
GCM
72
Graham Capital Management
Connecticut
– -$115K -147,758 Closed
CANY
73
Caxton Associates (New York)
New York
– -$84K -107,135 Closed
CM
74
Crestline Management
Texas
– -$51K -65,362 Closed
VF
75
Virtu Financial
New York
– -$48K -61,561 Closed
1 2
3
4

SPPI Hedge Fund Activity: Q3 2022 in Review

75 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q3 2022, worth a combined $22.7M — down 30% from $32.3M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of SPPI and 15 opened new positions — a net loss of 11 holders — while 25 trimmed existing stakes and 18 added.

The largest buyer was Acadian Asset Management, adding an estimated $1.05M. The largest seller was D.E. Shaw & Co, cutting an estimated $4.13M.

  • 75 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q3 2022, down from 86 in Q2 2022.
  • Funds reported $22.7M of Spectrum Pharmaceuticals Inc stock for Q3 2022, down 30% quarter-over-quarter.
  • 15 funds opened new Spectrum Pharmaceuticals Inc positions in Q3 2022 and 26 closed out, a net change of -11 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q3 2022 was Acadian Asset Management, an estimated $1.05M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q3 2022 was D.E. Shaw & Co, an estimated $4.13M sold.

Based on aggregated 13F filings for Q3 2022.